Abstract:This review delved into the intricate relationship between circadian clocks and physiological processes, emphasizing their critical role in maintaining homeostasis. Orchestrated by interlocked clock genes, the circadian timekeeping system regulates fundamental processes like the sleep-wake cycle, energy metabolism, immune function, and cell proliferation. The central oscillator in the hypothalamic suprachiasmatic nucleus synchronizes with light-dark cycles, while peripheral tissue clocks are influenced by cues such as feeding times. Circadian disruption, linked to modern lifestyle factors like night shift work, correlates with adverse health outcomes, including metabolic syndrome, cardiovascular diseases, infections, and cancer. We explored the molecular mechanisms of circadian clock genes and their impact on metabolic disorders and cancer pathogenesis. Specific associations between circadian disruption and endocrine tumors, spanning breast, ovarian, testicular, prostate, thyroid, pituitary, and adrenal gland cancers, are highlighted. Shift work is associated with increased breast cancer risk, with PER genes influencing tumor progression and drug resistance. CLOCK gene expression correlates with cisplatin resistance in ovarian cancer, while factors like aging and intermittent fasting affect prostate cancer. Our review underscored the intricate interplay between circadian rhythms and cancer, involving the regulation of the cell cycle, DNA repair, metabolism, immune function, and the tumor microenvironment. We advocated for integrating biological timing into clinical considerations for personalized healthcare, proposing that understanding these connections could lead to novel therapeutic approaches. Evidence supports circadian rhythm-focused therapies, particularly chronotherapy, for treating endocrine tumors. Our review called for further research to uncover detailed connections between circadian clocks and cancer, providing essential insights for targeted treatments. We emphasized the importance of public health interventions to mitigate lifestyle-related circadian disruptions and underscored the critical role of circadian rhythms in disease mechanisms and therapeutic interventions.

Evaluation of small-molecule modulators of the circadian clock: promising therapeutic approach to cancer

Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer

Major roles of the circadian clock in cancer

Circadian rhythms and new options for novel anticancer therapies

The Role of Circadian Rhythm in the Pathogenesis of Colorectal Cancer

Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer

The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer

Circadian rhythms in haematological malignancies: therapeutic potential and personalised interventions

Implications of biological clocks in pharmacology and pharmacokinetics of antitumor drugs

Exploring the role of circadian clock gene and association with cancer pathophysiology

Circadian rhythms and cancers: the intrinsic links and therapeutic potentials

Circadian rhythm as a therapeutic target

The Molecular Circadian Clock Is a Target of Anti-cancer Translation Inhibitors

The Circadian Clock as a Potential Biomarker and Therapeutic Target in Gastrointestinal Cancers

Can we utilise the circadian clock to target cancer stem cells?

The Relationship between Circadian Rhythm and Cancer Disease

Circadian rhythm disruption and endocrine-related tumors

The Role of Circadian Clocks in Cancer: Mechanisms and Clinical Implications

Roles of circadian clocks in cancer pathogenesis and treatment

Dysregulation, Functional Implications, and Prognostic Ability of the Circadian Clock Across Cancers

Circadian Timing in Cancer Treatments